Yahoo Web Search

Search results

    • Q1 2024 Panbela Therapeutics Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 4 hours ago

      This study is actively enrolling. The Phase II eflornithine trial in type 1 diabetes is a multi-center, double-blind, placebo-controlled 2:1 random assigned clinical trial led by Indiana ...